SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Andreas Samson who wrote (3106)12/7/1997 10:07:00 PM
From: DR. BOND  Read Replies (2) of 23519
 
Andreas....You asked alot of good questions that I am too tired to answer directly. But please allow me to make a quick summary opinion1

The ED market worldwide is approx 30 - 40 million men, most of whom never seeked treatment. MUSE has already proven itself to be an effective, reliable, easy to use ED therapy. In fact both Janssen and Astra Pharmaceutical agree and have signed joint marketing agreements w/VVUS. The co. will earn approx. $1.15 this year and approx. $1.90 to $2.10 next year. Estimates for 1999 from some houses are as high as $4.00! That's SUPERIOR EARNINGS GROWTH. Yes the stock has acted like a PIG recently, but if you look back in time with this stock, these underperforming periods are not only short lived but usually followed by EXPLOSIVE UPSIDE MOVES!

I could go on and on but I am watching the Miami game. Good luck!

Dr. Bond

PS. How did you do in ASND!
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext